Bio

Expert in cell & gene therapy across CMC, process development, R&D with an emphasis on sourcing risk & mitigation strategies. Work with business leaders to assess existing processes to identify gaps in order to recommend more efficient and stable cell & gene therapy manufacturing strategies. Industry experience across cell & gene therapy, cancer immunotherapy, medical devices and bioprocessing. Specialties include: Strategic opportunity assessment, new business development, KOL, development/management, cell-based starting materials, cryopreservation, product development, research & development and single-use materials.